Conflict of interest
The authors declare that they have no conflict of interest.
References
  1. Jerkic SP, Brinkmann F, Calder A, Casey A, Dishop M, Griese M,  Kurland G, Niemitz M, Nyilas S, Schramm D, Schubert R, Tamm M, Zielen S, Rosewich M. Postinfectious Bronchiolitis Obliterans in Children: Diagnostic Workup and Therapeutic Options: A Workshop Report. Can Respir J. 2020; 2020 : 5852827.
  2. Fischer GB, Sarria EE, Mattiello R, Mocelin HT, Castro-Rodriguez JA. Post infectious bronchiolitis obliterans in children. Paediatr Respir Rev. 2010;11(4) : 233-9.
  3. Li YN, Liu L, Qiao HM, Cheng H, Cheng HJ. Post-infectious bronchiolitis obliterans in children: a review of 42 cases. BMC Pediatr. 2014; 14 : 238.
  4. Colom AJ, Teper AM, Vollmer WM, Diette GB. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax. 2006; 61(6) : 503-6.
  5. Jinho Yu. Postinfectious bronchiolitis obliterans in children: lessons from bronchiolitis obliterans after lung transplantation and hematopoietic stem cell transplantation. Korean J Pediatr. 2015;58(12) : 459-65.
  6. Colom AJ, Teper AM. Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children. Pediatr Pulmonol. 2009; 44(11) : 1065-9.
  7. Colom AJ, Maffey A, Garcia Bournissen F, Teper A. Pulmonary Function of a Paediatric Cohort of Patients With Postinfectious Bronchiolitis Obliterans. A Long Term Follow-Up. Thorax. 2015; 70(2) : 169-74.
  8. Sisman Y, Buchvald F, Nielsen KG. Lung function and fitness in children treated for Post-infectious Bronchiolitis Obliterans. Eur Respir J. 2017; 50 : OA1763.
  9. Cazzato S, Poletti V, Bernardi F, Loroni L, Bertelli L, Colonna S, Zappulla F, Timoncini G, Cicognani A. Airway inflammation and lung function decline in childhood post-infectious bronchiolitis obliterans. Pediatr Pulmonol. 2008; 43(4) : 381-90.
  10. Mosquera RA, Hashmi SS, Pacheco SE, Reverdin A, Chevallier J, Colasurdo GN. Dysanaptic growth of lung and airway in children with post-infectious bronchiolitis obliterans. Clin Respir J. 2014;8 : 63-71.
  11. Mattiello R, Vidal PC, Sarria EE, Pitrez PM, Stein RT, Mocelin HT, Fischer GB, Jones MH, Pinto LA. Evaluating bronchodilator response in pediatric patients with post-infectious bronchiolitis obliterans: use of different criteria for identifying airway reversibility. J Bras Pneumol. 2016; 42(3) :174-8.
  12. Mattiello R, Sarria EE, Stein R, Fischer GB, Mocelin HT, Barreto SS, et al. Functional capacity assessment in children and adolescents with post-infectious bronchiolitis obliterans. J Pediatr. 2008;84(4) : 337-43.
  13. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J. 2005; 26(2) : 319-38.
  14. Castro-Rodriguez JA, Daszenies C, Garcia M, Meyer R, Gonzales R. Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatr Pulmonol. 2006;41(10): 947-53.
  15. Kim CK, Kim SW, Kim JS, KohYY, Cohen AH, Deterding RR, White CW. Bronchiolitis obliterans in the 1990s in Korea and the United States. Chest. 2001; 120(4) : 1101-6.
  16. Similä S, Linna O, Lanning P, Heikkinen E, Ala-Houhala M. Chronic lung damage caused by adenovirus type 7: a ten-year follow-up study. Chest. 1981; 80(2) : 127-31.
  17. Uyan ZS, Midyat L, Çakir E, Gökdemir Y, Sahin N. Azithromycin therapy in children with postinfectious bronchiolitis obliterans. Eur Respir J. 2016; 48 : PA1602.
  18. Aguerre V, Castaños C, Pena HG, Grenoville M, Murtagh P. Postinfectious bronchiolitis obliterans in children: Clinical and pulmonary function findings. Pediatr Pulmonol. 2010; 45(12) : 1180-5.
  19. Eckrich J, Herrmann E, Voss S, Schubert R, Zielen S, Rosewich M. Short-Term Variation of Lung Function and Airway Inflammation in Children and Adolescents With Bronchiolitis Obliterans. Lung. 2016;194(4) : 571-9.
  20. Narayanan M, Owers-Bradley J, Beardsmore CS, Mada M, Ball I, Garipov R, Panesar KS, Kuehni CE, Spycher BD, Williams SE, Silverman M. Alveolarization continues during childhood and adolescence: new evidence from helium-3 magnetic resonance. Am J Respir Crit Care Med. 2012; 185(2) : 186-91.
  21. Narayanan M, Beardsmore CS, Owers-Bradley J, Dogaru CM, Mada M, Ball I, Garipov RR, Kuehni CE, Spycher BD, Silverman M. Catch-up alveolarization in expreterm children. Evidence from 3He magnetic resonance. Am J Respir Crit Care Med. 2013; 187(10) : 1104-9.
  22. Pisi R, Aiello M, Zanini A, Tzani P, Paleari D, Marangio E, Spanevello A, Nicolini G, Chetta A. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015; 10 : 1191-7.
  23. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R,  Miller MR, Navajas D, edersen OFP, Wanger J. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26(5) : 948-68.
  24. Chung HL, Jang YY. Bronchial hyperresponsiveness observed in the children with postinfectious bronchiolitis obliterans: a long-term follow-up study. J Allergy Clin Immun. 2019; 143(2) : AB217.
  25. Yoo Y, Yu J, Kim DK, Choi SH, Kim CK, Koh YY. Methacholine and adenosine 5’-monophosphate challenges in children with post-infectious bronchiolitis obliterans. Eur Respir J. 2006; 27(1) : 36-41.
Table 1. Characteristics of the study subjects